文献速递小儿麻醉神经外科与老年麻醉

右美托咪定对新生大鼠七氟烷神经毒性的神经保护作用

Dexmedetomidine-mediated neuroprotection against sevoflurane-induced neurotoxicity extends to several brain regions in neonatal rats.
PubMed 文献 · Br J Anaesth · 2017-01-01

该研究在出生后7天的大鼠中评估右美托咪定对七氟烷诱导的神经毒性的保护作用。七氟烷暴露6小时使多个脑区活化 caspase-3 阳性细胞增加约10倍,联合右美托咪定1 µg/kg 显著减少各脑区凋亡,但5-25 µg/kg 与七氟烷联用呈剂量依赖性增加死亡率。

要点

  • 七氟烷暴露使新生大鼠多个脑区凋亡增加约10倍。
  • 右美托咪定1 µg/kg 联合七氟烷显著减少各脑区凋亡。
  • 右美托咪定5-25 µg/kg 联合七氟烷剂量依赖性增加死亡率。

核心结论

  • 七氟烷麻醉诱导新生大鼠脑广泛凋亡,右美托咪定1 µg/kg 联合给药提供显著保护,而5 µg/kg 或更高剂量联合七氟烷增加死亡率。

研究设计与样本

  • 出生后7天 infant rats 暴露于2.5%七氟烷6小时,期间腹腔注射生理盐水或右美托咪定(1-50 µg/kg)三次,评估麻醉深度、呼吸频率和动脉血气,用计算机化方法检测活化 caspase-3 免疫染色脑切片中的凋亡。

主要发现

  • 七氟烷单独诱导外科麻醉平面,所有动物存活。
  • 与未处理对照相比,七氟烷使多个皮层和皮层下脑区 AC-3 阳性细胞增加约10倍。
  • 右美托咪定1 µg/kg 联合七氟烷显著减少所有脑区凋亡,丘脑保护最高(减少84%),海马和皮层区域最低(减少约50%)。
  • 右美托咪定5-25 µg/kg 联合七氟烷剂量依赖性增加 infant rat 死亡率。

临床怎么用

  • 新生动物模型中右美托咪定1 µg/kg 联合七氟烷可减轻神经凋亡,但5 µg/kg 及以上与七氟烷联用增加死亡率,提示临床转化研究需谨慎选择剂量。

局限性

  • 本研究为新生大鼠动物实验,结果不能直接外推至临床。
  • 原文未报告样本量、P 值等统计细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Exposure of infant animals to clinically used anaesthetics is associated with acute structural brain abnormalities and development functional alterations. The α 2 -adrenoceptor agonist dexmedetomidine (DEX) induces sedation, analgesia, and provides neuroprotection in experimental brain injury models. However, it is unknown whether DEX also affords protection in the developing brain against anaesthesia using sevoflurane (SEVO), which is commonly used in paediatric anaesthesia. METHODS: Infant rats were exposed on postnatal day seven for six h to 2.5% SEVO and were given i.p. injections of saline or DEX (1-50 µg kg -1 ) three times during the exposure. Level of anaesthesia, respiratory rates, and arterial blood gasses were assessed for each animal. Apoptosis was determined in brain slices immunostained for activated caspase-3 (AC-3) using a computerised approach. RESULTS: SEVO alone induced a surgical plane of anaesthesia, and all animals survived the study. SEVO induced an approximately 10-fold increase in AC-3 positive cells in several cortical and subcortical brain regions compared with untreated control animals. Co-administration of DEX 1 µg kg -1 with SEVO significantly reduced apoptosis in all brain areas, affording the highest protection in the thalamus (84% reduction) and lowest in the hippocampus and cortical areas (∼50% reduction). DEX 5-25 µg kg -1 plus SEVO dose-dependently increased infant rat mortality. CONCLUSIONS: SEVO anaesthesia induced widespread apoptosis in infant rat brain. Co-administration of DEX (1 µg kg -1 ) provided significant protection, whereas DEX (5 µg kg -1 or higher) plus SEVO increased mortality. Our findings suggest that DEX could be an attractive therapeutic for future studies investigating its neuroprotective potential in a translational animal model.

来源:Br J Anaesth,查看原文。版权归原作者所有。

引用

  1. Perez-Zoghbi JF, Zhu W, Grafe MR, et al. Dexmedetomidine-mediated neuroprotection against sevoflurane-induced neurotoxicity extends to several brain regions in neonatal rats. Br J Anaesth. 2017. PMID: 28969317. doi:10.1093/bja/aex222

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。